Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :2140
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

BREAST - ORIGINAL ARTICLE

Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India

Ghosh J, Gupta S, Desai S, Shet T, Radhakrishnan S, Suryavanshi P, Parmar V, Jalali R, Goyal G, Hawaldar R, Patil A, Nair N, Badwe R A

Year : 2011| Volume: 48| Issue : 4 | Page no: 391-396

   This article has been cited by
 
1 Breast Cancer Demographics, Types and Management Pathways: Can Western Algorithms be Optimally used in Eastern Countries?
S. Chakraborty,T. Wadasadawala,R. Ahmed,C. Coles,S. Chatterjee
Clinical Oncology. 2019; 31(8): 502
[Pubmed]  [Google Scholar] [DOI]
2 Adjuvant Short-Course Trastuzumab in Breast Cancer
Taha Sethjiwala,Manikandan Dhanushkodi,Venkatraman Radhakrishnan,Jayachandran Perumal Kalaiarasi,Nikita Mehra,Archit Joshi,Arun Kumar Rajan,Gangothri Selvarajan,Balasubramanian Ananthi,Priya Iyer,Geetha Senguttuvan,Bharathi Srilatha,Rama Ranganathan,Shirley Sundersingh,Arvind Krishnamurthy,Sridevi Velusamy,Hemanth Raj,Selvaluxmy Ganesarajah,Tenali Gnana Sagar,Trivadi S. Ganesan
Indian Journal of Gynecologic Oncology. 2019; 17(3)
[Pubmed]  [Google Scholar] [DOI]
3 The Impact of Stage and Molecular Subtypes on Survival Outcomes in Young Women with Breast Cancer
Nisha Hariharan,T. Subramanyeshwar Rao,Chandra K. Naidu,K.V.V.N. Raju,Senthil Rajappa,Santa Ayyagari,M.V.T. Krishnamohan,Sudha Murthy,Aparna Suryadevara,Naren Boleneni
Journal of Adolescent and Young Adult Oncology. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?
Gertruud Haitsma,Himanshu Patel,Parthasarathi Gurumurthy,Maarten J. Postma
Expert Review of Pharmacoeconomics & Outcomes Research. 2018; 18(3): 289
[Pubmed]  [Google Scholar] [DOI]
5 Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population
Tabassum Wadasadawala,Shirley Lewis,Vani Parmar,Ashwini Budrukkar,Sudeep Gupta,Nita Nair,Tanuja Shet,Rajendra Badwe,Rajiv Sarin
Clinical Breast Cancer. 2018; 18(4): e727
[Pubmed]  [Google Scholar] [DOI]
6 Alarming Burden of Triple-Negative Breast Cancer in India
Krishan K. Thakur,Devivasha Bordoloi,Ajaikumar B. Kunnumakkara
Clinical Breast Cancer. 2018; 18(3): e393
[Pubmed]  [Google Scholar] [DOI]
7 Clinicopathological Profile of Breast Cancer Patients at a Tertiary Care Hospital in Kashmir Valley
Mujahid Ahmad Mir,Farzana Manzoor,Balvinder Singh,Wasim Raja,Shaukat Jeelani,Waheed Ahmad Zargar,Faraidon Faiq Ahmad,Aung Zar Ko,Imteyaz Ahmad Sofi
Surgical Science. 2017; 08(03): 162
[Pubmed]  [Google Scholar] [DOI]
8 Epidemiology of breast cancer in Indian women
Shreshtha Malvia,Sarangadhara Appalaraju Bagadi,Uma S. Dubey,Sunita Saxena
Asia-Pacific Journal of Clinical Oncology. 2017; 13(4): 289
[Pubmed]  [Google Scholar] [DOI]
9 Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients
Mukund Sable,Trupti D. Pai,Tanuja Shet,Asawari Patil,Sandeep Dhanavade,Sangeeta B. Desai
International Journal of Surgical Pathology. 2017; 25(3): 230
[Pubmed]  [Google Scholar] [DOI]
10 Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease
Jyothi S Prabhu,Aruna Korlimarla,C E Anupama,Annie Alexander,Rohini Raghavan,Roma Kaul,Krisha Desai,Savitha Rajarajan,Suraj Manjunath,Marjorrie Correa,R Raman,Anjali Kalamdani,MSN Prasad,Shekar Patil,K S Gopinath,B S Srinath,T.S. Sridhar
Translational Oncology. 2017; 10(4): 699
[Pubmed]  [Google Scholar] [DOI]
11 Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis
Gurprataap S. Sandhu,Sebhat Erqou,Heidi Patterson,Aju Mathew
Journal of Global Oncology. 2016; 2(6): 412
[Pubmed]  [Google Scholar] [DOI]
12 Clinicopathological Profile of Breast Cancer Patients at a Tertiary Care Hospital in Marathwada Region of Westen India
Unmesh Vidyadhar Takalkar,Shilpa Balaji Asegaonkar,Umesh Kulkarni,Pushpa R Kodlikeri,Ujwala Kulkarni,Mamta Saraf,Suresh Advani
Asian Pacific Journal of Cancer Prevention. 2016; 17(4): 2195
[Pubmed]  [Google Scholar] [DOI]
13 Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance
Vijay M. Patil,Vanita Noronha,Amit Joshi,Vamshi Muddu,Sachin Dhumal,Atanu Bhattacharjee,Kumar Prabhash
Journal of Global Oncology. 2015; 1(2): 65
[Pubmed]  [Google Scholar] [DOI]
14 Differences in Incidence, Mortality and Survival of Breast Cancer by Regions and Countries in Asia and Contributing Factors
Yeonju Kim,Keun-Young Yoo,Marc T Goodman
Asian Pacific Journal of Cancer Prevention. 2015; 16(7): 2857
[Pubmed]  [Google Scholar] [DOI]
15 Triple-Negative Breast Cancer among Ghanaian Women Seen at Korle-Bu Teaching Hospital
E. M. Der,R. K. Gyasi,Y. Tettey,T. M. Bayor,L. Newman
African Journal of Pathology and Microbiology. 2015; 4: 1
[Pubmed]  [Google Scholar] [DOI]
16 Clinical Trial Ethics: One Standard Does Not Fit All
Sudeep Gupta,Seema Gulia,Nishita Shetty
Journal of Clinical Oncology. 2015; 33(12): 1413
[Pubmed]  [Google Scholar] [DOI]
17 Drug repurposing in oncology—patient and health systems opportunities
Francesco Bertolini,Vikas P. Sukhatme,Gauthier Bouche
Nature Reviews Clinical Oncology. 2015; 12(12): 732
[Pubmed]  [Google Scholar] [DOI]
18 Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience
Edmund M. Der,Richard K. Gyasi,Yao Tettey,Lawrence Edusei,Marcel T. Bayor,Evelyn Jiagge,Mawuli Gyakobo,Sofia D. Merajver,Lisa A. Newman
The Breast Journal. 2015; 21(6): 627
[Pubmed]  [Google Scholar] [DOI]
19 result 1 Document A majority of low (1-10%) er positive breast cancers behave like hormone receptor negative tumors
Prabhu, J.S., Korlimarla, A., Desai, K., (...), Srinath, B.S., Sridhar, T.S.
Source of the Document Journal of Cancer. 2014;
[Pubmed]  [Google Scholar]
20 Differences in breast cancer hormone receptor status in ethnic groups: A London population
Jack, R.H. and Davies, E.A. and Renshaw, C. and Tutt, A. and Grocock, M.J. and Coupland, V.H. and Møller, H.
European Journal of Cancer. 2013; 49(3): 696-702
[Pubmed]  [Google Scholar]
21 Morphological profile and receptor status in breast carcinoma: An institutional study
Rao, C. and Shetty, J. and Kishan Prasad, H.L.
Journal of Cancer Research and Therapeutics. 2013; 9(1): 44-49
[Pubmed]  [Google Scholar]
22 Differences in breast cancer hormone receptor status in ethnic groups: A London population
Ruth H. Jack,Elizabeth A. Davies,Christine Renshaw,Andrew Tutt,Melanie J. Grocock,Victoria H. Coupland,Henrik Møller
European Journal of Cancer. 2013; 49(3): 696
[Pubmed]  [Google Scholar] [DOI]
23 Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast
Yang, M. and Xu, S.-P. and Ao, Q.-L.
Chinese Journal of Pathology. 2013; 42(4): 257-261
[Pubmed]  [Google Scholar]
24 Challenges in the management of breast cancer in low- and middle-income countries
Yip, C.-H. and Taib, N.A.
Future Oncology. 2012; 8(12): 1575-1583
[Pubmed]  [Google Scholar]
25 Challenges in the management of breast cancer in low- and middle-income countries
Cheng-Har Yip,Nur Aishah Taib
Future Oncology. 2012; 8(12): 1575
[Pubmed]  [Google Scholar] [DOI]
26 Challenges and opportunities in the design and implementation of breast cancer clinical trials in developing countries
Sudeep Gupta,Shona Nag,Shaheenah Dawood
Clinical Investigation. 2012; 2(6): 579
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow